Macroaxis: Personalized Investing
Simple Personalized Investing

SP 500   1,669   2.87  Index Moved Up 0.17%
MCD YUM CMG CMG Recent Drops Large Value Biotech Office Supplies 
United States GSPC USD ...  |  Check Insiders


Processing
Collecting data for WCRX and FRX ...

Asset Comparison and Correlation

    
Investment horizon: 
  30 Days    Login   to change
 
 Warner Chilcott plc  vs   Forest Laboratories Inc.
 Compare Fundamentals  
Daily Returns (%)
WCRX   FRX   
 
Given investment horizon of 30 days, Warner Chilcott plc is expected to generate 4.65 times more return on investment than Forest. However, Warner is 4.65 times more volatile than Forest Laboratories Inc. It trades about 0.4 of its potential returns per unit of risk. Forest Laboratories Inc is currently generating about 0.25 per unit of risk. If you would invest  1,360  in Warner Chilcott plc on April 21, 2013 and sell it today you would earn a total of  600  from holding Warner Chilcott plc or generate 44.12% return on investment over 30 days.

Diversification

Significant diversification
Overlapping area represents amount of risk that can be diversified away by holding Warner Chilcott plc and Forest Laboratories Inc. in the same portfolio assuming nothing else is changed

Correlation Coefficient

0.07
Parameters
Time Period1 Month [change]
DirectionPositive FRX Moved Up vs WCRX
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns
Follow Correlation between WCRX and FRX with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Correlation between WCRX and FRX to your reader
 
Share Correlation between WCRX and FRX 
Find Opportunities
 
Predicted Return Density
 
Returns   
WCRX   FRX   

Warner Chilcott plc

 
    
Warner
Performance
21
Out Of
100
Over 30
Days
79% of all equities and portfolios perform better than Warner Chilcott plc. Compared with the overall equity markets, risk-adjusted returns on investments in Warner Chilcott plc are ranked lower than 21 (%) of all global equities and portfolios over the last 30 days.
    

Match ups for Warner

Novo Nordisk A-S vs. Warner Chilcott plc
Teva Pharmaceutical Industries Limited vs. Warner Chilcott plc
Allergan Inc vs. Warner Chilcott plc
Forest Laboratories Inc vs. Warner Chilcott plc
Dr Reddys Laboratories Ltd vs. Warner Chilcott plc
Pharmacyclics Inc vs. Warner Chilcott plc
Endo Health Solutions Inc vs. Warner Chilcott plc
United Therapeutics Corporation vs. Warner Chilcott plc
Cubist Pharmaceuticals Inc vs. Warner Chilcott plc
  

Forest Laboratories Inc

 
    
Forest
Performance
13
Out Of
100
Over 30
Days
87% of all equities and portfolios perform better than Forest Laboratories Inc. Compared with the overall equity markets, risk-adjusted returns on investments in Forest Laboratories Inc are ranked lower than 13 (%) of all global equities and portfolios over the last 30 days.
    

Match ups for Forest

Novo Nordisk A-S vs. Forest Laboratories Inc
Teva Pharmaceutical Industries Limited vs. Forest Laboratories Inc
Allergan Inc vs. Forest Laboratories Inc
Dr Reddys Laboratories Ltd vs. Forest Laboratories Inc
Pharmacyclics Inc vs. Forest Laboratories Inc
Warner Chilcott plc vs. Forest Laboratories Inc
Endo Health Solutions Inc vs. Forest Laboratories Inc
United Therapeutics Corporation vs. Forest Laboratories Inc
Cubist Pharmaceuticals Inc vs. Forest Laboratories Inc


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium